Researchers develop DNA nanoswitch platform to screen protein interaction drug leads
Scientists have introduced a DNA nanoswitch platform called FIND that screens molecular libraries based on how candidate drugs alter protein-protein interactions.
FTMQ Science, written by our newsroom0 views
Researchers at the Wyss Institute at Harvard University, Boston Children's Hospital, and Harvard Medical School have developed a drug discovery platform named FIND, Bioengineer.org reported. The technology uses DNA nanoswitches to screen large chemical libraries for molecules that alter protein-protein interactions, which are the binding events between two proteins. The team published their findings in the journal Science. [1]
Bioengineer.org reported that the platform selects drug candidates based on how they alter interactions between proteins rather than testing whether a molecule binds to a single target protein. Using this approach, the researchers identified new drug leads for diabetes and other health disorders. The screen successfully identified both small molecules and nanobodies. [1]
In pharmaceutical sciences, drug interactions occur when the mechanism of action of a drug is altered by the administration of other substances, including foods, beverages, or additional drugs. One established example of a drug-food interaction is the effect of grapefruit on drug metabolism. [2]
The discovery builds on broader efforts to engineer protein tools for therapeutic applications. As FTMQ Science reported earlier, researchers at the Institute for Protein Design and NVIDIA developed an artificial intelligence model called RFD4-Proteina to design custom protein sequences and structures five to 10 times faster than earlier software. [3]
In short
- Researchers at Harvard University institutions and Boston Children's Hospital created the FIND drug discovery platform.
- The FIND platform uses DNA nanoswitches to test how molecules modulate protein-protein interactions.
- Scientists used the platform to identify drug leads for diabetes, including small molecules and nanobodies.
- The study describing the FIND platform was published in Science.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]DNA Nanoswitches Screen Protein Interactions for Drug LeadsBioengineer.org, 6d ago (the report this story comes from)
Background
- [2]Drug interaction on Wikipedia
- [3]AI model generates novel enzymes for drug synthesis FTMQ Science, 25d ago
Our newsroom writes these reports with the help of software, from the 3 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Science
Earlier reports of ours on the same people and subjects.
- Penn State Chemists Develop Technique to Convert Sulfonamides Into AnilinesTop Stories, 7d ago
- KAIST Chemists Build Unmanned Platform for Continuous Molecule SynthesisChemistry, 30d ago
- Researchers develop new CRISPR method to track plant RNA dynamicsBiology, 42d ago
- Researchers combine focused ultrasound and microRNAs to combat glioblastomaBody & Mind, 16d ago
- Harvard chemists drive chemical reactions using electricity at oil and water boundariesChemistry, 4h ago
More in Top Stories
- United States loses measles elimination status after year of continuous spread4h ago
- Physicists at CERN detect extremely rare particle interaction at zeptometer scale4h ago
- Researchers find evidence of massive ancient Baffin Bay ice shelf4h ago
- Excavations in southern Saudi Arabia reveal 125,000 year old prehistoric human site2d ago
- Ancient Danish skeleton shows individual dietary transition to farming2d ago
- Ancient Danish skeleton provides insights into shift to agriculture2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.